Directed Evolution of OgeuIscB With Enhanced Activity in Human Cells
- 25 April 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (8) , e70570
Abstract
The miniature RNA‐guided endonuclease IscB, as the evolutionary progenitor of Cas9, is attracting increased attention for genome editing due to its compact size and suitability for in vivo delivery. However, the poor editing efficiency of IscB in eukaryotic cells presents a significant challenge to its widespread application in precise site‐specific human genome editing. In this study, we employed structure‐guided rational design and protein engineering to optimize OgeuIscB, resulting in the identification of enIscB‐F138R, which further enhanced editing activity up to 3.49‐fold in mammalian cells compared to the high‐activity OgeuIscB variant enIscB. Furthermore, we engineered an enIscB‐F138R nickase‐based adenine base editor, termed miABE‐F138R, exhibiting enhanced base editing efficiency relative to miABE. To illustrate the practical applications of miABE‐F138R, we applied it to rectify the prevalent R560C mutation in Pde6β associated with autosomal recessive retinitis pigmentosa, resulting in a significant improvement in activity compared to miABE. In conclusion, enIscB‐F138R and miABE‐F138R offer adaptable platforms for genome editing with potential significance in future biomedical applications.Keywords
Funding Information
- Natural Science Foundation of Zhejiang Province (ZCLTGD24H1202, LTGD23H120001, LTGC23H120001)
- National Natural Science Foundation of China (82101169)
This publication has 44 references indexed in Scilit:
- Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryosMolecular Cell, 2024
- Cas12n nucleases, early evolutionary intermediates of type V CRISPR, comprise a distinct family of miniature genome editorsMolecular Cell, 2023
- The miniature CRISPR-Cas12m effector binds DNA to block transcriptionMolecular Cell, 2022
- A precise and efficient adenine base editorMolecular Therapy, 2022
- Engineered miniature CRISPR-Cas system for mammalian genome regulation and editingMolecular Cell, 2021
- Engineered FnCas12a with enhanced activity through directional evolution in human cellsJournal of Biological Chemistry, 2021
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavageNature, 2017
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavageNature, 2016
- Effect of Genome Size on AAV Vector PackagingMolecular Therapy, 2010
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic InjectionMolecular Therapy, 2008